GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BrainsWay Ltd (NAS:BWAY) » Definitions » Cyclically Adjusted Revenue per Share

BWAY (BrainsWay) Cyclically Adjusted Revenue per Share : $2.18 (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is BrainsWay Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

BrainsWay's adjusted revenue per share for the three months ended in Mar. 2025 was $0.625. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $2.18 for the trailing ten years ended in Mar. 2025.

During the past 12 months, BrainsWay's average Cyclically Adjusted Revenue Growth Rate was 11.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2025-05-18), BrainsWay's current stock price is $9.91. BrainsWay's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was $2.18. BrainsWay's Cyclically Adjusted PS Ratio of today is 4.55.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of BrainsWay was 5.38. The lowest was 2.74. And the median was 4.02.


BrainsWay Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for BrainsWay's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BrainsWay Cyclically Adjusted Revenue per Share Chart

BrainsWay Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1.88 2.04

BrainsWay Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.78 1.90 2.02 2.04 2.18

Competitive Comparison of BrainsWay's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, BrainsWay's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BrainsWay's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BrainsWay's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where BrainsWay's Cyclically Adjusted PS Ratio falls into.


;
;

BrainsWay Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BrainsWay's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.625/134.9266*134.9266
=0.625

Current CPI (Mar. 2025) = 134.9266.

BrainsWay Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.191 100.684 0.256
201509 0.236 100.392 0.317
201512 0.307 99.792 0.415
201603 0.327 100.470 0.439
201606 0.404 101.688 0.536
201609 0.425 101.861 0.563
201612 0.425 101.863 0.563
201703 0.290 102.862 0.380
201706 0.279 103.349 0.364
201709 0.396 104.136 0.513
201712 0.482 104.011 0.625
201803 0.421 105.290 0.540
201806 0.490 106.317 0.622
201809 0.523 106.507 0.663
201812 0.654 105.998 0.832
201903 0.598 107.251 0.752
201906 0.558 108.070 0.697
201909 0.541 108.329 0.674
201912 0.574 108.420 0.714
202003 0.362 108.902 0.449
202006 0.506 108.767 0.628
202009 0.498 109.815 0.612
202012 0.645 109.897 0.792
202103 0.446 111.754 0.538
202106 0.434 114.631 0.511
202109 0.447 115.734 0.521
202112 0.493 117.630 0.565
202203 0.400 121.301 0.445
202206 0.457 125.017 0.493
202209 0.308 125.227 0.332
202212 0.357 125.222 0.385
202303 0.382 127.348 0.405
202306 0.471 128.729 0.494
202309 0.500 129.860 0.520
202312 0.550 129.419 0.573
202403 0.547 131.776 0.560
202406 0.667 132.554 0.679
202409 0.635 133.029 0.644
202412 0.632 133.157 0.640
202503 0.625 134.927 0.625

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


BrainsWay  (NAS:BWAY) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

BrainsWay's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=9.91/2.18
=4.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of BrainsWay was 5.38. The lowest was 2.74. And the median was 4.02.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


BrainsWay Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of BrainsWay's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


BrainsWay Business Description

Industry
Traded in Other Exchanges
Address
19 Hartum Street, 3rd Floor, Bynet Building, Har Hotzvim, Jerusalem, ISR, 9777518
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.